he trade group for generic drug makers has filed a lawsuit charging that a new Maryland law designed to punish companies for price gouging is unconstitutional.

In making its case, the Association for Accessible Medicines argued the law violates interstate commerce by giving Maryland officials the right to govern business outside the state, effectively providing “unprecedented powers to regulate the national pharmaceutical market.” The trade group also maintained the law too vaguely defines “excessive” pricing, which would violate due process.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.